Phosphate Binders

Phosphate-Binder Swap Has Benefits

ORLANDO—Switching end-stage renal disease patients to lanthanum carbonate monotherapy from a phosphate binder therapy maintains their previous serum phosphorus control, and aids patient and physician satisfaction.

Sevelamer May Lower Death Risk

A study of new hemodialysis patients revealed that those treated with the phosphate binder sevelamer had a significantly lower death rate than those treated with calcium-containing phosphate binders.

Next post in News